Matthew Harrison
Stock Analyst at Morgan Stanley
(3.30)
# 972
Out of 4,784 analysts
730
Total ratings
46.35%
Success rate
1.77%
Average return
Main Sectors:
Stocks Rated by Matthew Harrison
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LEGN Legend Biotech | Maintains: Overweight | $82 → $80 | $35.39 | +126.05% | 11 | Mar 17, 2025 | |
| TSVT 2seventy bio | Maintains: Equal-Weight | $6 → $5 | $4.95 | +1.01% | 10 | Mar 14, 2025 | |
| TNYA Tenaya Therapeutics | Maintains: Overweight | $15 → $5 | $0.69 | +622.75% | 5 | Mar 12, 2025 | |
| GILD Gilead Sciences | Maintains: Overweight | $123 → $130 | $111.16 | +16.95% | 40 | Mar 11, 2025 | |
| DNLI Denali Therapeutics | Assumes: Overweight | $41 → $33 | $14.20 | +132.39% | 12 | Mar 7, 2025 | |
| LYV Live Nation Entertainment | Maintains: Buy | $160 → $178 | $128.08 | +38.98% | 1 | Feb 21, 2025 | |
| AVNT Avient | Upgrades: Buy | $56 | $38.33 | +46.10% | 2 | Feb 18, 2025 | |
| BIIB Biogen | Maintains: Equal-Weight | $192 → $157 | $140.33 | +11.88% | 51 | Feb 13, 2025 | |
| VRTX Vertex Pharmaceuticals | Maintains: Equal-Weight | $450 → $459 | $502.55 | -8.67% | 37 | Feb 11, 2025 | |
| INSM Insmed | Maintains: Overweight | $85 → $90 | $77.69 | +15.85% | 16 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $57 → $55 | $37.37 | +47.18% | 2 | Jan 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $70 → $38 | $32.12 | +18.31% | 24 | Jan 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $10 → $3 | $1.33 | +125.56% | 10 | Nov 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $1,235 → $1,184 | $635.83 | +86.21% | 50 | Nov 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $4 → $6 | $1.16 | +417.24% | 5 | Sep 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $2 → $6.88 | $3.02 | +127.81% | 9 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $165 → $200 | $71.81 | +178.51% | 34 | Jun 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $8 → $11 | $14.51 | -24.19% | 9 | Jun 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $38 → $8 | $1.79 | +346.93% | 4 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $515 → $510 | $593.47 | -14.06% | 24 | May 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $7 | $1.30 | +438.46% | 18 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $115 → $112 | $72.83 | +53.78% | 21 | Apr 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $34 | $15.54 | +118.73% | 14 | Apr 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $32 | $20.14 | +58.89% | 27 | Mar 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $21 → $19 | $2.00 | +850.00% | 3 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Underweight | $60 | $3.79 | +1,483.11% | 30 | Jul 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $12 → $13 | $1.89 | +587.83% | 4 | Mar 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $2 → $1 | $0.61 | +63.93% | 3 | Mar 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $13 → $10 | $17.88 | -44.07% | 9 | Mar 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $27 → $8 | $3.09 | +158.90% | 9 | Feb 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $57 → $44 | $25.50 | +72.55% | 28 | Feb 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $13 | $1.85 | +604.61% | 3 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $7 → $4 | $0.59 | +573.85% | 4 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $5 → $3 | $0.43 | +596.06% | 4 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $203 → $216 | $95.40 | +126.42% | 8 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $7 → $5 | $1.52 | +228.95% | 13 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $7 → $5 | $1.67 | +200.30% | 6 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $178 → $182 | $202.72 | -10.22% | 8 | Dec 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $12 → $9 | $3.06 | +194.12% | 13 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $30 → $40 | $43.58 | -8.21% | 6 | Nov 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $279 → $282 | $305.77 | -7.77% | 38 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $220 → $210 | $271.02 | -22.51% | 7 | Oct 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $55 → $52 | $25.01 | +107.92% | 5 | May 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $175 → $173 | $163.13 | +6.05% | 3 | Apr 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $61 → $57 | $8.66 | +558.20% | 9 | Mar 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $156 → $120 | $38.89 | +208.56% | 17 | Feb 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $145 → $148 | $28.39 | +421.31% | 19 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $88 → $82 | $87.60 | -6.39% | 4 | Nov 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $71 → $66 | $58.90 | +12.05% | 4 | Oct 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $43 → $39 | $1.88 | +1,974.47% | 4 | Aug 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $51 → $46 | $31.65 | +45.34% | 1 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $33 → $35 | $14.56 | +140.38% | 1 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $207 → $275 | $821.67 | -66.53% | 2 | Aug 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $19 | $1.81 | +949.72% | 1 | Jun 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $67 → $62 | $7.91 | +683.82% | 12 | Mar 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $16 → $17 | $15.12 | +14.09% | 3 | Feb 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $50 | $1.18 | +4,137.29% | 4 | Aug 18, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $89 → $83 | $60.68 | +36.78% | 1 | Jan 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $59 → $57 | $29.08 | +96.01% | 4 | Oct 11, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Equal-Weight | $10 | $42.99 | -76.74% | 4 | Sep 10, 2018 |
Legend Biotech
Mar 17, 2025
Maintains: Overweight
Price Target: $82 → $80
Current: $35.39
Upside: +126.05%
2seventy bio
Mar 14, 2025
Maintains: Equal-Weight
Price Target: $6 → $5
Current: $4.95
Upside: +1.01%
Tenaya Therapeutics
Mar 12, 2025
Maintains: Overweight
Price Target: $15 → $5
Current: $0.69
Upside: +622.75%
Gilead Sciences
Mar 11, 2025
Maintains: Overweight
Price Target: $123 → $130
Current: $111.16
Upside: +16.95%
Denali Therapeutics
Mar 7, 2025
Assumes: Overweight
Price Target: $41 → $33
Current: $14.20
Upside: +132.39%
Live Nation Entertainment
Feb 21, 2025
Maintains: Buy
Price Target: $160 → $178
Current: $128.08
Upside: +38.98%
Avient
Feb 18, 2025
Upgrades: Buy
Price Target: $56
Current: $38.33
Upside: +46.10%
Biogen
Feb 13, 2025
Maintains: Equal-Weight
Price Target: $192 → $157
Current: $140.33
Upside: +11.88%
Vertex Pharmaceuticals
Feb 11, 2025
Maintains: Equal-Weight
Price Target: $450 → $459
Current: $502.55
Upside: -8.67%
Insmed
Feb 6, 2025
Maintains: Overweight
Price Target: $85 → $90
Current: $77.69
Upside: +15.85%
Jan 31, 2025
Maintains: Buy
Price Target: $57 → $55
Current: $37.37
Upside: +47.18%
Jan 15, 2025
Maintains: Equal-Weight
Price Target: $70 → $38
Current: $32.12
Upside: +18.31%
Nov 26, 2024
Downgrades: Underweight
Price Target: $10 → $3
Current: $1.33
Upside: +125.56%
Nov 1, 2024
Maintains: Overweight
Price Target: $1,235 → $1,184
Current: $635.83
Upside: +86.21%
Sep 16, 2024
Maintains: Overweight
Price Target: $4 → $6
Current: $1.16
Upside: +417.24%
Aug 13, 2024
Upgrades: Equal-Weight
Price Target: $2 → $6.88
Current: $3.02
Upside: +127.81%
Jun 24, 2024
Maintains: Overweight
Price Target: $165 → $200
Current: $71.81
Upside: +178.51%
Jun 21, 2024
Maintains: Equal-Weight
Price Target: $8 → $11
Current: $14.51
Upside: -24.19%
Jun 18, 2024
Downgrades: Equal-Weight
Price Target: $38 → $8
Current: $1.79
Upside: +346.93%
May 28, 2024
Maintains: Overweight
Price Target: $515 → $510
Current: $593.47
Upside: -14.06%
May 9, 2024
Upgrades: Equal-Weight
Price Target: $7
Current: $1.30
Upside: +438.46%
Apr 26, 2024
Maintains: Overweight
Price Target: $115 → $112
Current: $72.83
Upside: +53.78%
Apr 22, 2024
Maintains: Overweight
Price Target: $34
Current: $15.54
Upside: +118.73%
Mar 26, 2024
Maintains: Underweight
Price Target: $32
Current: $20.14
Upside: +58.89%
Aug 14, 2023
Maintains: Equal-Weight
Price Target: $21 → $19
Current: $2.00
Upside: +850.00%
Jul 11, 2023
Reiterates: Underweight
Price Target: $60
Current: $3.79
Upside: +1,483.11%
Mar 27, 2023
Maintains: Equal-Weight
Price Target: $12 → $13
Current: $1.89
Upside: +587.83%
Mar 27, 2023
Maintains: Underweight
Price Target: $2 → $1
Current: $0.61
Upside: +63.93%
Mar 3, 2023
Maintains: Underweight
Price Target: $13 → $10
Current: $17.88
Upside: -44.07%
Feb 28, 2023
Downgrades: Equal-Weight
Price Target: $27 → $8
Current: $3.09
Upside: +158.90%
Feb 27, 2023
Maintains: Equal-Weight
Price Target: $57 → $44
Current: $25.50
Upside: +72.55%
Jan 24, 2023
Maintains: Overweight
Price Target: $15 → $13
Current: $1.85
Upside: +604.61%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $7 → $4
Current: $0.59
Upside: +573.85%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $5 → $3
Current: $0.43
Upside: +596.06%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $203 → $216
Current: $95.40
Upside: +126.42%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $7 → $5
Current: $1.52
Upside: +228.95%
Jan 24, 2023
Maintains: Overweight
Price Target: $7 → $5
Current: $1.67
Upside: +200.30%
Dec 6, 2022
Maintains: Overweight
Price Target: $178 → $182
Current: $202.72
Upside: -10.22%
Nov 14, 2022
Maintains: Equal-Weight
Price Target: $12 → $9
Current: $3.06
Upside: +194.12%
Nov 7, 2022
Maintains: Equal-Weight
Price Target: $30 → $40
Current: $43.58
Upside: -8.21%
Nov 4, 2022
Maintains: Overweight
Price Target: $279 → $282
Current: $305.77
Upside: -7.77%
Oct 28, 2022
Maintains: Equal-Weight
Price Target: $220 → $210
Current: $271.02
Upside: -22.51%
May 4, 2022
Maintains: Equal-Weight
Price Target: $55 → $52
Current: $25.01
Upside: +107.92%
Apr 6, 2022
Maintains: Equal-Weight
Price Target: $175 → $173
Current: $163.13
Upside: +6.05%
Mar 10, 2022
Maintains: Equal-Weight
Price Target: $61 → $57
Current: $8.66
Upside: +558.20%
Feb 1, 2022
Maintains: Overweight
Price Target: $156 → $120
Current: $38.89
Upside: +208.56%
Jan 7, 2022
Maintains: Equal-Weight
Price Target: $145 → $148
Current: $28.39
Upside: +421.31%
Nov 29, 2021
Maintains: Equal-Weight
Price Target: $88 → $82
Current: $87.60
Upside: -6.39%
Oct 12, 2021
Maintains: Equal-Weight
Price Target: $71 → $66
Current: $58.90
Upside: +12.05%
Aug 18, 2021
Maintains: Overweight
Price Target: $43 → $39
Current: $1.88
Upside: +1,974.47%
Aug 16, 2021
Maintains: Equal-Weight
Price Target: $51 → $46
Current: $31.65
Upside: +45.34%
Aug 16, 2021
Maintains: Equal-Weight
Price Target: $33 → $35
Current: $14.56
Upside: +140.38%
Aug 5, 2021
Maintains: Overweight
Price Target: $207 → $275
Current: $821.67
Upside: -66.53%
Jun 24, 2021
Initiates: Buy
Price Target: $19
Current: $1.81
Upside: +949.72%
Mar 8, 2021
Maintains: Overweight
Price Target: $67 → $62
Current: $7.91
Upside: +683.82%
Feb 24, 2021
Maintains: Equal-Weight
Price Target: $16 → $17
Current: $15.12
Upside: +14.09%
Aug 18, 2020
Downgrades: Equal-Weight
Price Target: $50
Current: $1.18
Upside: +4,137.29%
Jan 6, 2020
Maintains: Equal-Weight
Price Target: $89 → $83
Current: $60.68
Upside: +36.78%
Oct 11, 2018
Maintains: Overweight
Price Target: $59 → $57
Current: $29.08
Upside: +96.01%
Sep 10, 2018
Assumes: Equal-Weight
Price Target: $10
Current: $42.99
Upside: -76.74%